Literature DB >> 26662919

S1P1 deletion in oligodendroglial lineage cells: Effect on differentiation and myelination.

Danuta E Dukala1, Betty Soliven1.   

Abstract

Sphingosine 1-phosphate (S1P) receptors are G protein-coupled receptors expressed by many cell types, including cells of oligodendrocyte (OLG) lineage. We had previously shown that targeted deletion of S1P1 in OLG lineage cells did not result in obvious clinical phenotype or altered number of OLGs at 3 months, but there were subtle abnormalities in myelin. In this study, we examined the role of S1P1 in developmental myelination and cell survival, focusing on age 3 weeks. We found that S1P1 deficiency led to delayed differentiation of OLG progenitors (OPCs) into OLGs that is independent of p38 phosphorylation. This was accompanied by decreased levels of myelin basic protein (MBP) but not of myelin-OLG glycoprotein (MOG), and slight decrease in myelin thickness in the corpus callosum of S1P1 conditional knockout (CKO) mice. S1P1 -deficient OLGs exhibited slower process extension, which was associated with attenuated phosphorylation of extracellular signal regulated kinases (ERKs) and p21-activated kinases (PAKs), and with upregulation of tropomodulin1. Basal levels of pAkt were not affected, though expectedly, no response to a selective S1P1 agonist SEW2871 was observed. S1P1 -deficient OLGs did not exhibit increased cell death in response to cuprizone, tumor necrosis factor-α, or deprivation of nutrients and growth factors. We conclude that S1P1 signaling regulates OLG development, morphological maturation and early myelination.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  glial cells; multiple sclerosis; oligodendrocytes; sphingolipids

Mesh:

Substances:

Year:  2015        PMID: 26662919     DOI: 10.1002/glia.22949

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  10 in total

Review 1.  Biological Effects of Naturally Occurring Sphingolipids, Uncommon Variants, and Their Analogs.

Authors:  Mitchell K P Lai; Wee Siong Chew; Federico Torta; Angad Rao; Greg L Harris; Jerold Chun; Deron R Herr
Journal:  Neuromolecular Med       Date:  2016-07-08       Impact factor: 3.843

Review 2.  Crosstalk between sphingolipids and vitamin D3: potential role in the nervous system.

Authors:  Mercedes Garcia-Gil; Federica Pierucci; Ambra Vestri; Elisabetta Meacci
Journal:  Br J Pharmacol       Date:  2017-02-24       Impact factor: 8.739

3.  Visualizing Sphingosine-1-Phosphate Receptor 1(S1P1) Signaling During Central Nervous System De- and Remyelination.

Authors:  Ezzat Hashemi; Ezra Yoseph; Hsing-Chuan Tsai; Monica Moreno; Li-Hao Yeh; Shalin B Mehta; Mari Kono; Richard Proia; May H Han
Journal:  Cell Mol Neurobiol       Date:  2022-08-02       Impact factor: 4.231

Review 4.  G Protein-Coupled Receptors in Myelinating Glia.

Authors:  Amit Mogha; Mitchell D'Rozario; Kelly R Monk
Journal:  Trends Pharmacol Sci       Date:  2016-09-23       Impact factor: 14.819

5.  Dynamics of sphingolipids and the serine palmitoyltransferase complex in rat oligodendrocytes during myelination.

Authors:  Deanna L Davis; Usha Mahawar; Victoria S Pope; Jeremy Allegood; Carmen Sato-Bigbee; Binks W Wattenberg
Journal:  J Lipid Res       Date:  2020-02-10       Impact factor: 5.922

6.  Oscillatory calcium release and sustained store-operated oscillatory calcium signaling prevents differentiation of human oligodendrocyte progenitor cells.

Authors:  Richard A Seidman; Heba Khattab; Jessie J Polanco; Jacqueline E Broome; Fraser J Sim
Journal:  Sci Rep       Date:  2022-04-13       Impact factor: 4.379

Review 7.  Sphingosine 1-Phosphate Receptor 1 Signaling in Mammalian Cells.

Authors:  Nigel J Pyne; Susan Pyne
Journal:  Molecules       Date:  2017-02-23       Impact factor: 4.411

Review 8.  Mechanism of Siponimod: Anti-Inflammatory and Neuroprotective Mode of Action.

Authors:  Newshan Behrangi; Felix Fischbach; Markus Kipp
Journal:  Cells       Date:  2019-01-07       Impact factor: 6.600

Review 9.  Sphingosine-1-Phosphate Receptor Modulators and Oligodendroglial Cells: Beyond Immunomodulation.

Authors:  Alessandra Roggeri; Melissa Schepers; Assia Tiane; Ben Rombaut; Lieve van Veggel; Niels Hellings; Jos Prickaerts; Anna Pittaluga; Tim Vanmierlo
Journal:  Int J Mol Sci       Date:  2020-10-13       Impact factor: 5.923

Review 10.  The Two Sides of Siponimod: Evidence for Brain and Immune Mechanisms in Multiple Sclerosis.

Authors:  Stanley L Cohan; Ralph H B Benedict; Bruce A C Cree; John DeLuca; Le H Hua; Jerold Chun
Journal:  CNS Drugs       Date:  2022-06-20       Impact factor: 6.497

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.